ADMA holders · CITADEL ADVISORS LLC 13F · ADMA stock
CITADEL ADVISORS LLC ADMA Biologics Inc (ADMA) 13F holding
CITADEL ADVISORS LLC reported 3,290,987 ADMA shares valued at $29.65B as of 2026-03-31 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 3,290,987 | $29.65B | COM |
| 2026-03-31 | 2,519,655 | $22.70B | COM |
| 2026-03-31 | 316,500 | $2.85B | Call |
| 2026-03-31 | 120,100 | $1.08B | Put |
| 2025-12-31 | 978,429 | $17.85B | COM |
| 2025-12-31 | 544,141 | $9.93B | COM |
| 2025-12-31 | 261,300 | $4.77B | Call |
| 2025-12-31 | 110,600 | $2.02B | Put |
| 2025-09-30 | 1,660,141 | $24.34B | COM |
| 2025-09-30 | 912,200 | $13.37B | Call |
| 2025-09-30 | 459,021 | $6.73B | COM |
| 2025-09-30 | 231,000 | $3.39B | Put |
| 2025-06-30 | 245,000 | $4.46B | Put |
| 2025-06-30 | 187,100 | $3.41B | Call |
Not investment advice. Cached 13F row, not EDGAR XML.